Cannabis biotech company raises $750,000
DENVER — Next Frontier Biosciences, a company that specializes in cannabinoid products for chronic pain treatment, has raised $750,000.
The company plans to raise $2 million, according to a Form D filed with the Securities & Exchange Commission on Sept. 1.
Next Frontier did not return a request for comment. The company is offering equity to raise the funds, according to the Form D.
SPONSORED CONTENT
Business Cares: May 2024
As Mental Health Awareness Month unfolds in Colorado, it serves as a reminder of the collective responsibility to prioritize mental well-being.
The company’s initial product launch in Colorado is planned for the third quarter of this year, according to its website. The company has a nasal mist, sublingual spray and topical salve that it has developed.
DENVER — Next Frontier Biosciences, a company that specializes in cannabinoid products for chronic pain treatment, has raised $750,000.
The company plans to raise $2 million, according to a Form D filed with the Securities & Exchange Commission on Sept. 1.
Next Frontier did not return a request for comment. The company is offering equity to raise the funds, according to the Form D.
The company’s initial product launch in Colorado is planned for the third quarter of this year, according to its website. The company has a nasal mist, sublingual spray…
THIS ARTICLE IS FOR SUBSCRIBERS ONLY
Continue reading for less than $3 per week!
Get a month of award-winning local business news, trends and insights
Access award-winning content today!
